ONE Asset, a backer of Indian unicorns such as Swiggy and PharmEasy, has so far garnered Rs 7,062 crore ($810 million) in commitments for its thematic funds focused on technology, financial services, ...
Indian asset management company 360 ONE Asset, through its managed funds, has agreed to acquire a 15% stake in Bharti AXA ...
A financial services industry veteran who has worked with alternative investment group Xander and asset management firm 360 ONE in ..... Akasa Air said Thursday it is raising fresh capital from ...
ONE Silver ETF opened for subscription today, March 10, 2025, and will end on March 20, 2025. The scheme will reopen for ...
AI-driven healthcare startup Qure.ai has raised USD 65 million in its Series D funding round led by Lightspeed and 360 ONE Asset, with participation from other prominent investors such as Merck ...
5:14 We Don’t Need G20 As A Proof Of Recovery, Says K Subramanian Executive Director Of IMF What is the best performing Equity Scheme of 360 ONE Asset Management Limited in 3 years? The best ...
Mirae Asset Focused Fund Regular Growth. 360 ONE Focused Equity Fund Regular Growth has a sharpe ratio of 0.52 & a standard deviation of 13.59%. Is 360 ONE Focused Equity Fund Regular Growth good ...
Its investment manager, 360 ONE Alternates Asset Management Ltd (AAML), is a wholly-owned subsidiary of 360 ONE WAM Ltd. BLVPL is a holding company within the Bharti Group, which owns Bharti AXA Life.
360 One trades at a 40X price-to-earnings multiple ... the deal takes it closer to the full-service model (i.e., wealth, asset management and capital markets verticals), we are not sure if this ...
On listed equity front, 360 ONE Asset diligently provided investors with numerous updates on product performance and features and continued to onboard new distribution partners and achieve scale ...
Akasa Air said Thursday it is raising fresh capital from PremjiInvest and Claypond Capital, the family offices of Wipro founder ..... 360 ONE Asset has crossed the halfway mark of its maiden ...
OneSource is one of the few Indian CDMOs capable of developing and manufacturing advanced products such as GLP-1 drugs, similar to the compounds found in the popular diabetes and obesity drug ...